- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| DATAMEDS AI Aktie jetzt für 0€ handeln | |||||
| Fr | DataMEDS AI, Inc.: DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities | 446 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMEDS AI," "DataMEDS," or the "Company"), an integrated healthcare company leveraging its Health IT infrastructure... ► Artikel lesen | |
| Mi | DataMeds AI subsidiary adds GLP-1 drugs, reports July revenue | 5 | Investing.com | ||
| Mi | DataMEDS AI, Inc.: DataMeds AI Provides Update on Corexa Health's Pharmacy Division | 1.372 | ACCESS Newswire | GLP-1 agonist drugs now availableIntegration of online store CorexaRx.com into Health Lives Here app now completeMedical foods Forzet & Galectovid, and dietary supplement Tollovid now availableRevenue... ► Artikel lesen | |
| Mo | DataMeds AI renames pharmacy subsidiaries to Corexa | 1 | Investing.com | ||
| Mo | DataMEDS AI, Inc.: DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division | 1.187 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx... ► Artikel lesen | |
| 07.08. | DataMeds AI, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 06.08. | DataMEDS AI, Inc.: DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date | 414 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx... ► Artikel lesen | |
| 05.08. | DataMEDS AI, Inc.: DataMeds AI to be Featured In-Person on Fox Business' Claman Countdown to Introduce "Health Lives Here" | 450 | ACCESS Newswire | Initiative with NFL Alumni Health is aimed at improving rural healthcare access by powering Health Lives Here consumer app that integrates Einstein AI with independent pharmacies and proprietary patient... ► Artikel lesen | |
| 04.08. | DataMeds AI, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.07. | DataMEDS AI, Inc.: DataMeds AI's Corexa Pharmacy Launches Tollo Health's Tollovid and Galactovid | 654 | ACCESS Newswire | Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store TAMPA, FL / ACCESS Newswire / July 31, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI" or the "Company")... ► Artikel lesen | |
| 29.07. | DataMEDS AI, Inc.: DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License | 555 | ACCESS Newswire | Data monetization and real-world asset tokenization technologies licensed into the DataMeds AI's EinsteinRX PlatformHealthcare data represents 30%+ of global data assets growing by 36% per annum; DVLT... ► Artikel lesen | |
| 27.07. | DataMEDS updates meme coin distribution record date to August 7 | 2 | Investing.com | ||
| 27.07. | DataMEDS AI verschiebt Stichtag für Meme-Coin-Ausschüttung und erhöht Zuteilungsverhältnis | 3 | Investing.com Deutsch | ||
| 27.07. | DataMEDS AI, Inc.: DataMEDS AI Announces Updated August 7, 2026 Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders | 383 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / July 27, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS," or the "Company"), a health information technology leader implementing EinsteinRx artificial intelligence prescription... ► Artikel lesen | |
| 22.07. | DataMEDS AI, Inc.: DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets | 426 | ACCESS Newswire | Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS... ► Artikel lesen | |
| 21.07. | Wellgistics Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.07. | Wellgistics Health, Inc. Officially Changes Corporate Name To DataMEDS AI, Inc. | 344 | PR Newswire | Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data
TAMPA, Fla.... ► Artikel lesen | |
| 20.07. | Wellgistics Health, Inc.: Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders | 634 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / July 20, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx artificial intelligence prescription... ► Artikel lesen | |
| 15.07. | Wellgistics Health appoints Brett Thompson as consulting CTO | 2 | Seeking Alpha | ||
| 15.07. | Wellgistics Health ernennt Brett Thompson zum beratenden Chief Technology Officer | 1 | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
100 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CANOPY GROWTH | 0,862 | +0,98 % | Canopy Growth Corporation: Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows | Renewed certification maintains Kincardine's role in Canopy Growth's EU GMP flower supply chain
Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX: WEED) (Nasdaq: CGC)... ► Artikel lesen | |
| EYEPOINT | 11,700 | -8,59 % | EyePoint, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | ||
| FILANA THERAPEUTICS | 0,795 | +0,63 % | Filana Therapeutics, Inc.: Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update | AUSTIN, Texas, July 29, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, "Filana Therapeutics", the "Company"), a biotechnology company currently focused on developing therapies for... ► Artikel lesen | |
| COMPASS PATHWAYS | 11,500 | -1,71 % | Warum Lillys 3,8-Milliarden-Dollar-Deal den Psychedelika-Sektor verändert - und warum Emyria jetzt in den Fokus rücken könnte | ||
| CORBUS PHARMACEUTICALS | 8,630 | 0,00 % | Mizuho lowers Corbus Pharmaceuticals stock price target on model updates | ||
| DARE BIOSCIENCE | 0,900 | -3,23 % | Daré Bioscience, Inc.: Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women's Health Strategy Advances | Company launches Flora Sync LF5, the company's first directly commercialized product, began generating revenue in July DARE to PLAY Sildenafil Cream progressing toward national dispensing and initial... ► Artikel lesen | |
| CITIUS PHARMACEUTICALS | 0,753 | -0,29 % | Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update | $7.1 Million in revenue for the first nine months of fiscal 2026 from commercial sales of LYMPHIR ®
$17 million in cash and cash equivalents as of June 30, 2026
Expanded... ► Artikel lesen | |
| ELEDON PHARMACEUTICALS | 3,240 | +5,88 % | Eledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights | Successful End-of-Phase 2 meeting with FDA supports advancement of tegoprubart into a global Phase 3 kidney transplantation trial, on track to initiate in late 2026 Long-term Phase 2 BESTOW data presented... ► Artikel lesen | |
| EXICURE | 0,885 | +0,57 % | EXICURE, INC. - 10-Q, Quarterly Report | ||
| COSMOS HEALTH | 0,186 | -0,59 % | Cosmos Health Inc.: Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels | Digital subscription platform brings together the Company's proprietary consumer health products across consumer (B2C) and corporate (B2B) channelsCustomers can begin through one of three paths: a free... ► Artikel lesen | |
| CHINA SXT PHARMACEUTICALS | 3,380 | -7,62 % | XFRA NEW INSTRUMENTS AVAILABLE ON 10.08.2026 | The following instruments on XETRA do have their first trading 10.08.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.08.2026
Aktien
1 KYG472811036 IMC Rare Earths Ltd.
2... ► Artikel lesen | |
| CHAMPIONS ONCOLOGY | 4,560 | +4,11 % | Champions Oncology, Inc.: Champions Oncology Reports Record Annual Revenue of $59 Million | Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / July 27, 2026 / Champions Oncology, Inc. (Nasdaq:CSBR), a global leader in clinically relevant oncology... ► Artikel lesen | |
| CUMBERLAND PHARMACEUTICALS | 7,830 | +0,51 % | Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports Company Update & Q2 2026 Financial Results | $100 million Strategic Transaction Closed
Special Shareholder Dividend Funded
Advancing Late Stage Clinical Pipeline
NASHVILLE, Tenn., Aug. 4, 2026 /PRNewswire/... ► Artikel lesen | |
| CDT EQUITY | 3,050 | +4,45 % | CDT Equity Inc. - 10-Q, Quarterly Report | ||
| ANBIO BIOTECHNOLOGY | 8,200 | -0,61 % | Anbio Biotechnology - 6-K, Report of foreign issuer |
DATAMEDS AI INC gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,440 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DATAMEDS AI INC finden Sie auf Wallstreet Online.